Extracorporeal Membrane Oxygenation to Support COVID-19 Patients: A Propensity-Matched Cohort Study.

ABSTRACT:

Background

In patients with severe respiratory failure from COVID-19, extracorporeal membrane oxygenation (ECMO) treatment can facilitate lung-protective ventilation and may improve outcome and survival if conventional therapy fails to assure adequate oxygenation and ventilation. We aimed to perform a confirmatory propensity-matched cohort study comparing the impact of ECMO and maximum invasive mechanical ventilation alone (MVA) on mortality and complications in severe COVID-19 pneumonia.

Materials and methods

All 295 consecutive adult patients with confirmed COVID-19 pneumonia admitted to the intensive care unit (ICU) from March 13^th, 2020, to July 31^st, 2021 were included. At admission, all patients were classified into 3 categories: (1) full code inc

SUBMITTER: Stessel B 

PROVIDER: S-EPMC10279486 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature